Press release
Investigation announced for Long-Term Investors in FOXO Technologies Inc. (NYSE American: FOXO) shares
An investigation on behalf of investors in FOXO Technologies Inc. (NYSE American: FOXO) shares over potential wrongdoing.
Investors who purchased shares of FOXO Technologies Inc. (NYSE American: FOXO) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain FOXO Technologies directors breached their fiduciary duties and caused damage to the company and its shareholders.
Minneapolis, MN based FOXO Technologies Inc., a technology platform company, focuses on commercializing longevity science through products and services that serve the life insurance industry.
On February 24, 2022, FOXO Technologies Inc entered into a definitive merger agreement with special purpose acquisition company Delwinds Insurance Acquisition Corp. ("Delwinds") (NYSE: DWIN).
On September 15, 2022, FOXO Technologies Inc launched its initial public offering ("IPO") through a reverse merger with a special purpose acquisition company ("SPAC"), Delwinds. The stock opened for trading at $7.29 per share.
On November 14, 2022, FOXO Technologies Inc Technologies postponded its Third Quarter 2022 Earnings Report and Conference Call.
On November 14, 2022, FOXO Technologies Inc Technologies announced the departure of Chief Product Officer, Erin Sharoni.
Shares of FOXO Technologies Inc. (NYSE American: FOXO) declined to as low as $0.418 per share on November 17, 2022.
Those who purchased shares of FOXO Technologies Inc. (NYSE American: FOXO) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Long-Term Investors in FOXO Technologies Inc. (NYSE American: FOXO) shares here
News-ID: 2923925 • Views: …
More Releases from Shareholders Foundation
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made.
If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have…
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for FOXO
Peraso Inc. (NASDAQ: PRSO) Revolutionizes Mobile Signal Connectivity in Motion-B …
Peraso Inc. (NASDAQ: PRSO), a leader in 60GHz mmWave technology, has launched the PRM2141X-D-a major advancement in its PERSPECTUS product line. Purpose-built for high-mobility and wearable applications, this dual-polarized module delivers stable, multi-gigabit wireless performance even in motion-heavy or body-mounted environments.
Powered by Peraso's proprietary X720 60GHz chipset, the PRM2141X-D enables dynamic switching and polarization diversity-solving real-world challenges where traditional mmWave systems fail. With plug-and-play factory calibration, support for SuperSpeed USB…
Epigenetics Market Regional Growth Technological Advancements and Recent Innovat …
The epigenetics market has witnessed significant growth over the past years, with a market size valued at an impressive US$ 14.70 billion in 2023. This promising market is predicted to continue its upward trajectory, projected to reach a remarkable US$ 61.15 billion by 2033. The anticipated compound annual growth rate (CAGR) of 15.32% from 2024 to 2033 reflects the sector's robust potential. The driving forces behind this rapid expansion include…
Epigenetics Market Analysis, Trends, Growth, Research And Forecast 2033
The Business Research Company recently released a comprehensive report on the Global Epigenetics Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The epigenetics market size has grown…
Bioinformatics Market Increasing Demand, Growth Analysis and Future Outlook by 2 …
The global bioinformatics market is anticipated to grow at a CAGR of 12.3% during the forecast period (2024-2031). The rising prevalence of chronic diseases like cancer and genetic disorders increases demand for advanced bioinformatics tools and solutions. Bioinformatics plays a crucial role in analyzing vast amounts of genomic data to identify genetic variations associated with diseases and develop targeted therapies. The growing adoption of next-generation sequencing (NGS) technologies has generated…
Bioinformatics Market Share, Trends, Growth, Analysis and Forecast 2023-2030
The global bioinformatics market is anticipated to grow at a CAGR of 12.3% during the forecast period (2023-2030). The rising prevalence of chronic diseases like cancer and genetic disorders increases demand for advanced bioinformatics tools and solutions. Bioinformatics plays a crucial role in analyzing vast amounts of genomic data to identify genetic variations associated with diseases and develop targeted therapies. The growing adoption of next-generation sequencing (NGS) technologies has generated…
Bioinformatics Market is Anticipated to Increase at a Stable CAGR over the Forec …
The global bioinformatics market is anticipated to grow at a CAGR of 12.3% during the forecast period (2023-2030). The rising prevalence of chronic diseases like cancer and genetic disorders increases demand for advanced bioinformatics tools and solutions. Bioinformatics plays a crucial role in analyzing vast amounts of genomic data to identify genetic variations associated with diseases and develop targeted therapies. The growing adoption of next-generation sequencing (NGS) technologies has generated…
